Gil Block

Dr Gil Block is CMO at Reset Pharma. Dr Block has over 30 years of pharmaceutical and biotechnology experience encompassing all phases of clinical development and translational medicine; focusing primarily on neurologic and neuroinflammatory diseases, rare and ultra-rare orphan disorders, psychiatric diseases and pain. Some positions Dr. Block previously held include; Head of Clinical Neurology and Neuropharmacology at Merck and Co. Research Laboratories and Clinical Section Head of Global Neuroscience Development at AstraZeneca,